Chest pain in female-pattern heart disease is linked with abnormal heart blood flow, a new Cedars-Sinai Heart Institute study shows. The effect was demonstrated with a drug commonly used to alleviate chest pain patients with coronary artery disease, which was found to be ineffective in patients with moderate female-pattern heart disease, but may offer some relief for sicker patients.

Preventing blood clots with drugs such as heparin has become a common practice for fighting some heart and lung conditions, and for certain surgeries. But patients who take them also need their blood to clot to heal incisions made during operations. Researchers are developing a new way to tackle this problem — by pairing snake venom with nanofibers. Their study using the therapy on rats appears in the journal ACS Biomaterials Science & Engineering.

November 12, 2015 — A pharmacist-physician collaborative effort to control blood pressure among a diverse group of patients was considered cost-effective, according to new research in the American Heart Association’s journal Hypertension. Researchers found that a $22 price tag increased the hypertension control rate by 1 percent.


Computed tomography has seen rapid growth in all segments of medicine over the past two decades, and recent advances may further expand use of cardiac computed tomography angiography (CCTA). Advocates for cardiac CT speaking at the 2015 meetings of the American College of Cardiology (ACC), Society of Cardiovascular Computed Tomography (SCCT) and Transcatheter Cardiovascular  Therapeutics (TCT) laid out the latest technological advancements and outlined new clinical trial data that may help CT become a first-line, one-stop-shop cardiac imaging modality in the near future. 
Neovasc, Tiara, transcatheter mitral valve, TMVR
Valtech, Cardioband, transcatheter annuloplasty
MitralAlign, transcatheter annuloplasty

(This article was updated in June 2018)

The advent of transcatheter valve repair and replacement technologies is one of those rare instances where there is a rapid paradigm shift in medicine. Since the first transcatheter aortic valve replacement (TAVR) systems were cleared by the U.S. Food and Drug Administration (FDA) in 2011 (Edwards Lifesciences Sapien) and 2014 (Medtronic CoreValve), TAVR rapidly expanded. It is also fueling enthusiasm for new transcatheter mitral valve replacement (TMVR) technology.

Chronic Total Occlusion Summit (CTO)

Sposnored by the Cardiovascular Research Foundation (CRF), the event brings together leaders in the field of CTOs. the Chronic Total Occlusion Summit: A Live Case Demonstration Course will be held in the heart of New York City. Sessions will emphasize both advanced techniques and evidence-based medicine, with a heavy reliance on live case transmissions featuring the world’s leading experts in CTO PCI.

Imaging tests of obese children — some as young as 8 years old — showed signs of significant heart disease and heart muscle abnormalities, according to research presented at the American Heart Association’s Scientific Sessions 2015.

Two of the country’s preeminent health organizations, the American Heart Association (AHA) and the American Medical Association (AMA), announced a new nationwide initiative aimed at addressing the growing burden of high blood pressure in the United States.

Brigham and Women’s Hospital in Boston and Boehringer Ingelheim announced the results of a new interim analysis from a long-term study evaluating the safety and effectiveness of Pradaxa (dabigatran etexilate mesylate) relative to warfarin in routine clinical practice.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now